[ACRX] YoY Quarter Result on 31-Mar-2023 [#Q1]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
10-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- 171.31%
YoY- 163.89%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Revenue 0 442 511 386 265 343 3,109 -
PBT 64 -8,674 -8,956 -15,925 -13,674 -11,592 -15,551 -
Tax -5,273 -321 858 843 627 136 -2,704 11.76%
NP 5,337 -8,353 -8,956 -15,925 -13,674 -11,592 -15,551 -
Tax Rate 8,239.06% - - - - - - -
Total Cost -5,337 8,795 9,467 16,311 13,939 11,935 18,660 -
Ratio Analysis
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
NP Margin 0.00 -1,889.82 -1,752.64 -4,125.65 -5,160.00 -3,379.59 -500.19 -
Per Share
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
EPS 0.49 -1.15 -1.58 -3.98 -3.47 -4.55 -6.86 -
EPS Diluted 0.49 -1.15 -1.58 -3.98 -3.47 -4.55 -6.86 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.